What is the recommended management of acute colonic pseudo‑obstruction (Ogilvie syndrome) in an adult hospitalized patient presenting with abdominal distension and massive colonic dilatation without mechanical obstruction?

Management of Ogilvie Syndrome (Acute Colonic Pseudo-Obstruction)

Initial conservative management should be attempted for 24-48 hours with aggressive supportive care, followed by neostigmine administration if no improvement occurs, with colonoscopic decompression reserved for neostigmine failure, and surgery only for perforation, ischemia, or persistent failure of all other measures.

Initial Assessment and Risk Stratification

Upon presentation with abdominal distension and radiographic evidence of colonic dilatation >6 cm without mechanical obstruction, immediately assess for:

• Signs of perforation or ischemia (peritonitis, free air, pneumatosis, portal venous gas, hemodynamic instability)
• Cecal diameter - critical threshold is 12 cm, with perforation risk increasing significantly above this
• Duration of symptoms - risk of perforation increases after 3-6 days
• Systemic toxicity (fever, tachycardia, leukocytosis, lactic acidosis)

If any signs of perforation, ischemia, or hemodynamic instability are present, proceed directly to emergency surgery 1.

Conservative Management (First 24-48 Hours)

For hemodynamically stable patients without peritonitis:

• Bowel rest (NPO status)
• Nasogastric tube decompression if significant gastric distension or vomiting
• Rectal tube placement for distal decompression
• Aggressive IV fluid resuscitation to correct hypovolemia
• Correct electrolyte abnormalities (particularly potassium, magnesium, calcium)
• Discontinue all contributing medications (opioids, anticholinergics, calcium channel blockers)
• Mobilize the patient - reposition every 2 hours, encourage ambulation if possible
• Serial abdominal exams every 4-6 hours
• Serial imaging to monitor colonic diameter progression

2, 3, 4

Critical pitfall: Do not delay escalation of therapy beyond 24-48 hours if no clinical improvement occurs, as mortality increases significantly with delayed intervention 1, 3.

Pharmacologic Intervention: Neostigmine

If conservative measures fail after 24-48 hours and cecal diameter remains >9-12 cm:

Neostigmine 2-2.5 mg IV over 3-5 minutes with continuous cardiac monitoring 2, 3, 5

• Prerequisites: Rule out mechanical obstruction, correct electrolytes, ensure no contraindications (bradycardia, active bronchospasm, recent MI, mechanical urinary obstruction)
• Monitoring: Continuous telemetry during and for 30 minutes after administration
• Have atropine 0.6-1.2 mg at bedside for symptomatic bradycardia
• Response typically occurs within 10-30 minutes if effective
• Can repeat dose after 3-4 hours if initial response inadequate but some improvement noted
• Success rate approximately 60-90% for initial decompression

5

Endoscopic Decompression

Indicated if:

• Neostigmine fails or is contraindicated
• Recurrence after initial neostigmine success
• Cecal diameter >12 cm with clinical deterioration

Colonoscopic decompression should be performed by experienced endoscopist:

• Decompress to splenic flexure (right colon decompression is primary goal)
• Consider placement of decompression tube for sustained effect
• Success rate 60-95% but recurrence common (up to 40%)
• Can be repeated if recurrence occurs

2, 3

Major caveat: Avoid colonoscopy if signs of ischemia or impending perforation are present, as instrumentation increases perforation risk 3.

Surgical Intervention

Absolute indications for immediate surgery 1:

• Free perforation with peritonitis
• Documented ischemia or necrosis
• Massive hemorrhage with hemodynamic instability
• Clinical deterioration despite maximal medical/endoscopic therapy

Surgical options:

• Cecostomy (tube or surgical) for decompression in high-risk patients
• Segmental resection if localized ischemia/necrosis
• Subtotal colectomy with ileostomy for diffuse ischemia or perforation

Evidence Quality and Clinical Decision-Making

The provided guidelines [1-6] focus primarily on inflammatory bowel disease and toxic megacolon rather than Ogilvie syndrome specifically. However, the principles regarding timing of surgery for colonic dilatation are applicable. The research evidence [7-8] consistently supports a stepwise approach: conservative → neostigmine → colonoscopy → surgery.

Key finding from highest quality research: A 2018 retrospective study 4 of 37 patients found that conservative management had significantly fewer complications (21%) compared to interventional management (61%), with no difference in mortality or length of stay. This supports initial conservative management with selective escalation rather than aggressive early intervention.

The critical balance: While conservative management is often successful, the 27-57% mortality rate associated with perforation 1 mandates close monitoring and timely escalation. Serial examinations every 4-6 hours and repeat imaging at 24-48 hours are essential to avoid therapeutic inertia.

Monitoring for Treatment Failure

Escalate therapy immediately if:

• Cecal diameter increases beyond 12 cm
• Development of peritoneal signs
• Persistent fever >48-72 hours
• Rising lactate or white blood cell count
• Worsening abdominal pain despite decompression attempts
• Hemodynamic deterioration

The transverse colon is the most common site of perforation in pseudo-obstruction (unlike mechanical obstruction where cecum is most vulnerable) 1.